Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $121,867 | $138,639 | $156,595 | $171,340 | $177,011 |
| Gross Profit | $112,914 | $127,744 | $143,560 | $154,047 | $157,261 |
| Operating Income | $6,360 | $7,489 | $8,452 | $8,499 | $7,862 |
| Net Income | $4,572 | $6,104 | $6,025 | $5,987 | $5,980 |
Over the five-year period, Elevance Health’s top-line revenue has shown steady growth, increasing from 121,867 million USD in 2020 to 177,011 million USD in 2024. The revenue growth was strongest between 2020 and 2021 (approximately 13.7%) and maintained similar double-digit increases through 2022, although the growth rate slowed noticeably in 2023 and 2024 to around 9.5% and 3.3%, respectively. Gross profit trends mirror this pattern, rising consistently from 112,914 million USD in 2020 to 157,261 million USD in 2024, though growth rates tapered in later years. This suggests that while the company continues to expand its scale, competitive pressures or cost challenges may be increasingly constraining profit expansion. Operating income displays a less consistent pattern, with an increase from 6,360 million USD in 2020 to a peak of 8,499 million USD in 2023, followed by a decline to 7,862 million USD in 2024. Notably, net income experienced a significant jump of about 33.6% from 4,572 million USD in 2020 to 6,104 million USD in 2021—a substantial swing likely reflecting operational efficiencies or favorable market conditions—but then stabilized around 6,000 million USD in the subsequent years. Operating in a heavily regulated health insurance industry, these trends indicate a robust business model with mild slowing in revenue acceleration and profitability in recent years. Overall, Elevance Health appears financially sound, yet the deceleration in growth and slight contraction in operating income in 2024 warrant close monitoring to ensure sustained long-term performance in a competitive and evolving market.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.